Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.


TSX:CPH - Post by User

Bullboard Posts
Comment by Stylesson Aug 24, 2015 8:33pm
69 Views
Post# 24047647

RE:CPH State

RE:CPH State
0buylowsellhigh wrote: I agree that technically CPH is shedding itself to around north of $5. I sold when it past $13. This does not take the sweat off my brow. Fundamentally CPH needs to get its sales act together and better qtr's. With world wide stock capitulation things will get worse. All markets suffer from lack of trust. The FED needs to be clear as to its true intentions. China needs to come clean as to its state in real estate, oil and other commodity holdings as well as levels of debt across the board. So, technically, fundamentally and overall market conditions are NOT in CPH's favour. Happy$$$Hunting!!!


I'm sure Lieseeker is getting ready to suggest i'm using multiple IDs .can't handle anyone else having a simliar view that CPH looks like a dud. ha
Bullboard Posts